Ad
related to: fda approved anticancer drug review and prices freegoodrx.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung ...
(Reuters) -The U.S. Food and Drug Administration on Tuesday approved Johnson & Johnson's chemotherapy-free combination treatment for a type of non-small cell lung cancer, setting up a challenge ...
AstraZeneca's application was based on positive late-stage data that showed the drug improved overall survival and progression-free survival in patients with a type of lung cancer, whose disease ...
The U.S. Food and Drug Administration (FDA) approved trastuzumab emtansine in February 2013, and granted the application for Kadcyla to Genentech. [18] The FDA granted the application for trastuzumab emtansine priority review and breakthrough therapy designations. [24] In 2013, trastuzumab emtansine was approved in the UK, [4] and the EU. [6]
The U.S. Food and Drug Administration (FDA) granted zanubrutinib priority review, accelerated approval, breakthrough therapy, and orphan drug designations. [ 10 ] [ 15 ] [ 23 ] The FDA approved zanubrutinib in November 2019, and granted the application for Brukinsa to BeiGene USA Inc. [ 10 ] [ 15 ] [ 24 ]
Avelumab is FDA approved for the treatment of metastatic merkel-cell carcinoma. It failed phase III clinical trials for gastric cancer. [33] Durvalumab (Imfinzi) is a fully human IgG1 antibody developed by AstraZeneca. Durvalumab is FDA approved for the treatment of urothelial carcinoma and unresectable non-small cell lung cancer after ...
Nirogacestat was approved for medical use in the United States in November 2023. [2] It is the first medication approved by the US Food and Drug Administration (FDA) for the treatment of desmoid tumors. [2] [5] The FDA considers it to be a first-in-class medication. [6]
The Food and Drug Administration (FDA) has recently approved a blood test screening for colorectal cancer that has an over 83% success rate at detecting the presence of this form of cancer.
Ad
related to: fda approved anticancer drug review and prices freegoodrx.com has been visited by 100K+ users in the past month